What I am working with: 98.4% · batch certificate. I have read the primary source rather than the summary, which has left me with more questions. I understand the…
All questions
Newest first. 5.2k questions across 107 tags.
This came up because two published schedules for the same agent differ. I have read the primary source rather than the summary, which has left me with more questions.…
Stated plainly: ATTAIN-1 · 4 mg. I have read the primary source rather than the summary, which has left me with more questions. I understand the headline. I do not…
For context, I am working with a 10 mg presentation and a 2 mL fill. I noticed this today and I have not touched anything since, in case the state is diagnostic. I…
I am asking about the protocol logic rather than about my own case specifically. I can parse the result. I am less sure what it licenses me to conclude. I have…
What I have: racemisation · retatrutide · 2–8 °C. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like to know…
Numbers first: eGFR · dulaglutide. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum viable…
Details up front: FLOW · retatrutide. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
Numbers first: 98.2% · Janoshik · 97.9%. I have a result I cannot explain, and I would rather diagnose it than guess. I have checked the obvious explanations and…
Concretely: ecnoglutide · 3.33 mg/mL. Please show the division. I want to check my own against yours. I would like the general form as well as the specific number, so…
The case in front of me: ecnoglutide · 20 mg/mL · ten weeks. The claim is plausible, which is exactly why I want to check it. I am able to read a paper if someone…
The particulars: 37 °C · ecnoglutide. Somebody stated this to me confidently and I would like to check it before repeating it. I would accept a well-reasoned negative…
The specifics, since they change the answer: liraglutide · 30 °C · three days. I would like to define my thresholds before I have a result, for obvious reasons. I…
The specifics, since they change the answer: tirzepatide · ten weeks · 2–8 °C. I would like to define my thresholds before I have a result, for obvious reasons. I…
The particulars: 15 mg · 4 mg/mL. I would rather understand the derivation than memorise the outcome. Two people I asked gave two answers that differ by a factor of…
The specifics, since they change the answer: deamidation · 40 °C. I would like the mechanism, because I want to be able to reason about the cases nobody has written…
Stated plainly: orforglipron · 20 mg/mL · sixteen weeks. This is asserted often enough that I assumed it was established, and then I went looking for the source. I…
Stated plainly: orforglipron · 15 mg. I have worked this out and I would like someone to find the error, because I suspect there is one. My working so far, for the…
Setup, so nobody has to ask: Suzhou · Canada. I would like help reading this properly rather than being told what conclusion to reach. I have the full report…
Setup, so nobody has to ask: 97.9% · sampling plan. I would like help reading this properly rather than being told what conclusion to reach. I have the full report…
Setup, so nobody has to ask: 5 mg · 5 mL · bacteriostatic water · oral semaglutide. I would like to set this up properly once, rather than adjust it repeatedly. My…
Numbers first: a GLP-1 receptor agonist · sixteen weeks · minus 80 °C. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may…
Numbers first: a laboratory refrigerator · dulaglutide. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell…
The case in front of me: SURMOUNT-2 · 30 mg. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…